Figure 4.
Representative IHC staining of tumor TMA and association of FcγRIIB protein expression with PFS for DLBCL patients treated withR-CHOP or G-CHOP in GOYA. TMA sections were stained by IHC for FcγRIIB (brown) and CD68 (red) and assessed by light microscopy. (A) Representative images show ×40 magnification of varying levels of tumor FcγRIIB illustrating negative, weak, medium, and high staining (representative IHC for the Arthur cohort is presented in Arthur et al34). (B) Examples of FcγRIIB on macrophages and corresponding ×63 magnification showing low and high expression. (C) Correlation of FCGR2B expression by RNA-seq with FcγRIIB protein expression on tumor and macrophages. Kaplan-Meier curves for PFS based on FcγRIIB protein expression on (D) tumors* and (E) macrophages.*

Representative IHC staining of tumor TMA and association of FcγRIIB protein expression with PFS for DLBCL patients treated withR-CHOP or G-CHOP in GOYA. TMA sections were stained by IHC for FcγRIIB (brown) and CD68 (red) and assessed by light microscopy. (A) Representative images show ×40 magnification of varying levels of tumor FcγRIIB illustrating negative, weak, medium, and high staining (representative IHC for the Arthur cohort is presented in Arthur et al34). (B) Examples of FcγRIIB on macrophages and corresponding ×63 magnification showing low and high expression. (C) Correlation of FCGR2B expression by RNA-seq with FcγRIIB protein expression on tumor and macrophages. Kaplan-Meier curves for PFS based on FcγRIIB protein expression on (D) tumors* and (E) macrophages.*

Close Modal

or Create an Account

Close Modal
Close Modal